The Latest Life Sciences Tools & Diagnostics Articles from Streetwise Reports


Technical Analyst: Medical Device Stock Looking Set to Reverse

Contributed Opinion
  ()
Technical analyst Clive Maund charts the stock of this company that has developed a device that uses a special light that visualizes cancer during minimally invasive surgery. read more >

Health Technology Company Recuperating Well

Contributed Opinion
  ()
Technical analyst Clive Maund charts a medical technology firm and explains why he believes it is an interesting speculative play. read more >

Bacteria Test Developer Reiterates Revenue Should Double in 2019

Research Report
  ()
The product expected to drive that outcome is discussed in an H.C. Wainwright & Co. report. read more >
News Update

Healthcare Firm Partners on Genetic Testing for Cannabis, Medication Responses

News Update
  ()
The offering should facilitate a more individualized treatment plan for patients. read more >
News Update

Health Tech Firm to Pilot Artificial Intelligence-Powered Patient Monitoring Tool

News Update
  ()
This effort is one way the company can innovatively offer patients care. read more >
News Update

Biotech Achieves Development Milestone for Blue Light Imaging System

News Update
  ()
The surgical imaging firm continues to advance its first medical device toward commercialization. read more >
News Update

Innovative Healthcare Tech Firm to Acquire Two Vancouver Pharmacies

News Update
  ()
The transaction will allow the company to add a prescription fill and fulfillment component to its telemedicine app. read more >
News Update

Firm Signs Paid Pilot Agreements to Test Telemedicine Platform in 5 States

News Update
  ()
With this development, the Canadian company further expands its U.S. footprint. read more >

Premier Health Group Adding Medical Cannabis Support Tool

  ()
This clinical decision support software integration is the first of its kind, according to the company. read more >

5 Small-Caps on Fund Manager Steve Palmer's Radar Screen

  ()
Steve Palmer, Founding Partner, President and Chief Investment Officer for AlphaNorth Asset Management, talks about a handful of companies in diverse industries that have his attention. read more >

Health Tech Firm Completes Enrollment for Female Sexual Function Trial

Research Report
  ()
A Ladenburg Thalmann report reviewed the study design and purpose. read more >

Anixa Doesn't Disappoint

Contributed Opinion
  ()
Daniel Carlson of Tailwinds Research explains why he has designated this company his 2019 stock of the year. read more >
Showing Results: 1 to 12 of 12

Get Our Streetwise Reports Life Sciences Report Newsletter Free and be the first to know!

A valid email address is required to subscribe

More Experts

"DRRX's capital raise takes care of financing overhang on the stock." ❭
– Francois Brisebois, Laidlaw & Company